Comparing Medical Productivity between Germany and the US

Han de Vries; Dana P. Goldman; Geoffrey Joyce

doi:10.5771/9783845211794

Comparing Medical Productivity between Germany and the US

An Assessment of Differences and Trends in Costs, Treatments and Outcomes for Acute Myocardial Infarction and Colorectal Cancer

Reihe: Beiträge zum Gesundheitsmanagement

Band 23 1. Auflage 2008

Kein Zugriff

doi.org/10.5771/9783845211794
ISBN print: 978-3-8329-3915-1
ISBN online: 978-3-8452-1179-4
Nomos, Baden-Baden Nomos, Baden-Baden

Im Shop erwerben

Zusammenfassung

Die vorliegende Studie, die von der RAND Health Division im Auftrag der Techniker Krankenkasse durchgeführt wurde, zeigt anhand von zwei untersuchten Krankheitsbildern auf, wie sich die Behandlungsqualität in den Gesundheitssystemen der USA und Deutschlands verbessern und die Effizienz steigern lässt.

Abstract

Die vorliegende Studie, die von der RAND Health Division im Auftrag der Techniker Krankenkasse durchgeführt wurde, zeigt anhand von zwei untersuchten Krankheitsbildern auf, wie sich die Behandlungsqualität in den Gesundheitssystemen der USA und Deutschlands verbessern und die Effizienz steigern lässt.

Kapitel Ausklappen | EinklappenAutorenSeiten
2–20 Titelei/Inhaltsverzeichnis Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 2–20
21–26 Chapter 1: Introduction 21–26
- 21–23 1.1 Objectives and Research Questions Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 21–23
- 23–24 1.2 Relevance Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 23–24
- 24–24 1.3 Summary of Key Findings Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 24–24
- 24–26 1.4 Organization of the Remainder of the Report Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 24–26
27–38 Chapter 2: Background 27–38
- 27–29 2.1 Treatment of Colorectal Cancer and AMI 27–29
  - 27–28 2.1.1 Treatment of Colorectal Cancer Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 27–28
  - 28–29 2.1.2 Treatment of AMI Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 28–29
- 29–34 2.2 Existing Estimates of the Cost Attributable to Colorectal Cancer and AMI 29–34
  - 29–30 2.2.1 Estimating Cost Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 29–30
  - 30–32 2.2.2 Estimating the Costs of Colorectal cancer Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 30–32
    - 2.2.2.1 Variations in Cost Estimates
    - 2.2.2.2 Factors that Determine the Costs of Colorectal Cancer
  - 32–34 2.2.3 Estimating the Costs of AMI Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 32–34
    - 2.2.3.1 Variations in Cost Estimates
    - 2.2.3.2 Factors that Determine the Costs of AMI
- 34–38 2.3 Characteristics of the German and US Health Care Systems 34–38
  - 34–35 2.3.1 The German Health Care System Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 34–35
  - 35–36 2.3.2 The US Health Care System Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 35–36
  - 36–38 2.3.3 A Rough Comparison of the Two Systems Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 36–38
39–50 Chapter 3: Methods 39–50
- 39–43 3.1 Data 39–43
  - 39–41 3.1.1 General Characteristics Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 39–41
  - 41–43 3.1.2 Data Transformations Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 41–43
- 43–44 3.2 Study Sample Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 43–44
- 44–50 3.3 Statistical Analysis 44–50
  - 44–48 3.3.1 Total Costs of Disease Treatment Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 44–48
  - 48–49 3.3.2 Treatment and Diagnostic Procedures Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 48–49
  - 49–49 3.3.3 Prices Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 49–49
  - 49–50 3.3.4 Outcomes Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 49–50
51–72 Chapter 4: Results 51–72
- 51–52 4.1 Demographics Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 51–52
- 52–60 4.2 Co-morbidities 52–60
  - 52–57 4.2.1 Co-morbidities Identified by ICD codes Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 52–57
  - 57–60 4.2.2 Co-morbdities Identified by Prescription Drug Use Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 57–60
- 60–61 4.3 Total Costs Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 60–61
- 61–67 4.4 Treatments Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 61–67
- 67–69 4.5 Prices Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 67–69
- 69–69 4.6 Outcomes Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 69–69
- 69–72 4.7 Quality of Care Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 69–72
73–86 Chapter 5: Changes in Treatment Costs and Outcomes over Time 73–86
- 73–78 5.1 Costs Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 73–78
- 78–83 5.2 Treatments Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 78–83
- 83–86 5.3 Readmissions and Mortality Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 83–86
87–94 Chapter 6: Discussion 87–94
- 87–89 6.1 Cost Differences between the US and Germany Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 87–89
- 89–90 6.2 Explaining cost differences Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 89–90
- 90–91 6.3 Other explanations of cost differences Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 90–91
- 91–92 6.4 Outcomes Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 91–92
- 92–94 6.5 Study limitations Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 92–94
95–98 Chapter 7: Conclusion and Recommendations 95–98
- 95–96 7.1 Conclusion Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 95–96
- 96–98 7.2 Recommendations Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 96–98
99–100 Literature Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 99–100
101–106 Appendix 1: Matching of Procedures Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 101–106
107–122 Appendix 2: Matching of Co-morbidities Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 107–122
123–158 Appendix 3: Cost Models Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 123–158
159–172 Appendix 4: Models for Treatments, Length of Stay and Readmissions Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 159–172
173–194 Appendix 5: Models for Prices Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 173–194
195–196 Acknowledgement Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 195–196
197–198 Authors Dana P. Goldman, Geoffrey Joyce, Han de Vries Dana P. Goldman, Geoffrey Joyce, Han de Vries 197–198

Durchsuchen Sie das Werk

Geben Sie ein Keyword in die Suchleiste ein

Diese Webseite verwendet Cookies

[#IABV2_TITLE#]

Comparing Medical Productivity between Germany and the US

Zusammenfassung

Abstract

Durchsuchen Sie das Werk